These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8352181)

  • 21. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
    Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.
    Torjesen PA; Birkeland KI; Anderssen SA; Hjermann I; Holme I; Urdal P
    Diabetes Care; 1997 Jan; 20(1):26-31. PubMed ID: 9028689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the Magenstrasse and Mill operation for obesity on plasma plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrinogen and insulin.
    Carmichael AR; Tate G; King RF; Sue-Ling HM; Johnston D
    Pathophysiol Haemost Thromb; 2002; 32(1):40-3. PubMed ID: 12214162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment.
    Valle Jiménez M; Martos R; Morales RM; Valle R; Cañete MD; Urbano MM; Bermudo F; Cañete R
    Ann Nutr Metab; 2013; 63(3):216-22. PubMed ID: 24135306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM; Anderson JL; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2005 Aug; 150(2):243-50. PubMed ID: 16086925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.
    Båvenholm P; de Faire U; Landou C; Efendic S; Nilsson J; Wiman B; Hamsten A
    Eur Heart J; 1998 Mar; 19(3):402-10. PubMed ID: 9568444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index.
    Agren A; Wiman B; Schulman S
    J Intern Med; 2008 Dec; 264(6):586-92. PubMed ID: 18783478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator, tissue plasminogen activator inhibitor and lipoprotein(a) in patients with coronary, epiaortic and peripheral occlusive artery disease.
    Caputo M; Mantini G; Floriani I; Ciceri M; Noseda A; Bonomo L
    Eur Heart J; 1996 Sep; 17(9):1329-36. PubMed ID: 8880017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
    Rallidis LS; Megalou AA; Papageorgakis NH; Trikas AG; Chatzidimitriou GI; Tsitouris GK
    Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease.
    Romm PA; Green CE; Reagan K; Rackley CE
    Am J Cardiol; 1991 Mar; 67(6):479-83. PubMed ID: 1671804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance--a risk factor for coronary heart disease?
    Garcia-Webb P; Bonser AM; Whiting D; Masarei JR
    Scand J Clin Lab Invest; 1983 Dec; 43(8):677-85. PubMed ID: 6364321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis.
    Fujii S; Goto D; Zaman T; Ishimori N; Watano K; Kaneko T; Okada H; Makiguchi M; Nakagawa T; Kitabatake A
    J Atheroscler Thromb; 1998; 5(2):76-81. PubMed ID: 10855561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
    Aso Y; Wakabayashi S; Yamamoto R; Matsutomo R; Takebayashi K; Inukai T
    Diabetes Care; 2005 Sep; 28(9):2211-6. PubMed ID: 16123492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
    Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B
    J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.
    Olofsson BO; Dahlén G; Nilsson TK
    Eur Heart J; 1989 Jan; 10(1):77-82. PubMed ID: 2495219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin.
    Juhan-Vague I; Roul C; Alessi MC; Ardissone JP; Heim M; Vague P
    Thromb Haemost; 1989 Jun; 61(3):370-3. PubMed ID: 2678583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.